Summary & Overview
CPT 11980: Subdermal Hormone Pellet Insertion
CPT code 11980 covers the subdermal insertion of hormone pellets that release synthetic testosterone and/or estradiol for management of menopausal symptoms in women and testosterone deficiency in men. This procedure is an outpatient, office-based or ambulatory practice service used in hormone replacement strategies that aim to provide sustained hormone delivery over weeks to months. Nationally, the code is relevant for payers and providers managing long-acting hormone therapies and for benefit design around procedure-based hormone delivery.
Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna, UnitedHealthcare, and Medicare. Readers will find a concise clinical context for the procedure, typical sites of service, and which payers commonly cover or adjudicate claims for this service. The publication summarizes coverage considerations, common modifiers used in billing, and where data is not available in the input.
This content provides benchmarks and policy-focused context useful for billing managers, revenue cycle teams, and clinicians who refer or perform subdermal hormone pellet insertion. It highlights where further documentation and diagnosis mapping may be required for coverage determinations. Data not available in the input is explicitly noted so readers understand limitations of the source material.
Billing Code Overview
CPT code 11980 describes the subdermal insertion of hormone pellets. The procedure involves inserting small synthetic hormone pellets, typically containing testosterone and/or estradiol, beneath the skin — most commonly in the subcutaneous tissue of the upper arm. The pellets release hormones over time to treat menopausal symptoms in women or testosterone deficiency in males.
-
Service type: Hormone pellet insertion (subdermal hormonal therapy)
-
Typical site of service: Outpatient clinic, physician office, or ambulatory procedure setting with access to minor procedure supplies and wound care resources.
Data not available in the input for associated taxonomies, ICD-10 diagnoses, and related codes.
Clinical & Coding Specifications
Clinical Context
A 52-year-old female with symptomatic menopause presents to an outpatient women's health clinic for management of persistent vasomotor symptoms, sleep disturbance, and decreased libido despite trial of transdermal estrogen. After shared decision-making, the clinician recommends subdermal hormone pellet therapy. The procedure is performed in an ambulatory procedure room: informed consent is obtained, pre-procedure vitals and targeted history (contraindications, clotting history, current anticoagulants) are reviewed, and the insertion site (typically the subcutaneous tissue of the upper gluteal or lateral hip region or subdermal tissue of the upper arm) is marked. Local infiltration anesthesia is given, a small incision or trocar site is created, and one or more hormone pellets (testosterone and/or estradiol per prescription) are inserted subdermally. Hemostasis is achieved, the incision is closed with adhesive strips or a single suture if needed, and a sterile dressing is applied. Post-procedure instructions include activity restrictions, wound care, and follow-up for pellet performance and side-effect monitoring. Billing uses code 11980 for the subdermal insertion of hormone pellets; documentation includes indication, informed consent, number and type of pellets placed, site, anesthesia, any complications, and aftercare instructions.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
25 | Significant, separately identifiable E/M service on the same day |